It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Unmanageable bleeding is one of the significant causes of mortality. Attaining rapid hemostasis ensures subject survivability as a first aid during combats, road accidents, surgeries that reduce mortality. Nanoporous fibers reinforced composite scaffold (NFRCS) developed by a simple hemostatic film-forming composition (HFFC) (as a continuous phase) can trigger and intensify hemostasis. NFRCS developed was based on the dragonfly wing structure's structural design. Dragonfly wing structure consists of cross-veins and longitudinal wing veins inter-connected with wing membrane to maintain the microstructural integrity. The HFFC uniformly surface coats the fibers with nano thickness film and interconnects the randomly distributed cotton gauge (Ct) (dispersed phase), resulting in the formation of a nanoporous structure. Integrating continuous and dispersed phases reduce the product cost by ten times that of marketed products. The modified NFRCS (tampon or wrist band) can be used for various biomedical applications. The in vivo studies conclude that the developed Cp NFRCS triggers and intensifies the coagulation process at the application site. The NFRCS could regulate the microenvironment and act at the cellular level due to its nanoporous structure, which resulted in better wound healing in the excision wound model.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Department of Pharmaceutics, Manipal, India (GRID:grid.411639.8) (ISNI:0000 0001 0571 5193)
2 Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Department of Biotechnology, Manipal, India (GRID:grid.411639.8) (ISNI:0000 0001 0571 5193)
3 Kasturba Medical College, Manipal Academy of Higher Education, Department of Immunohematology and Blood Transfusion, Manipal, India (GRID:grid.411639.8)
4 Indian Institute of Technology, Department of Mechanical Engineering, Madras, India (GRID:grid.417969.4) (ISNI:0000 0001 2315 1926)
5 Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Department of Pharmacology, Manipal, India (GRID:grid.411639.8) (ISNI:0000 0001 0571 5193)